CORD-19:00a0ab182dc01b6c2e737dfae585f050dcf9a7a5 / 54298-54540
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/00a0ab182dc01b6c2e737dfae585f050dcf9a7a5","sourcedb":"CORD-19","sourceid":"00a0ab182dc01b6c2e737dfae585f050dcf9a7a5","text":"Patient 1 also had a comparatively increased level of IL-1o (with its immunosuppressive role (Sabat, 2010) ), a spike in CXCL10 (a proinflammatory role) late in the course of disease and both patients had raised IL-17A (also proinflammatory).","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T27","span":{"begin":0,"end":242},"obj":"Sentence"}],"attributes":[{"subj":"T27","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T294","span":{"begin":0,"end":242},"obj":"Sentence"},{"id":"T16869","span":{"begin":0,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T294","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T16869","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#93cfec","default":true},{"id":"CORD-19-Sentences","color":"#e9ec93"}]}]}}